The growing demand for controlled immunological research and therapeutic creation has spurred significant improvements in recombinant cytokine manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently manufactured using diverse expression platforms, including bacterial hosts, mammalian cell populations, a